Privacy Policy

Updated on: 17/01/25

Table of Contents
1) PREAMBLE

This document describes the ways in which we operate the website www.recordatirarediseases.com (“Website”) with respect to the processing of the personal data of its users. The Website is managed by Recordati AG, Rare Diseases Branch, with registered office in Uferstrasse 90, 4057 Basel, Switzerland.


When you browse our Wesbite, interact with us, or use our services (“Services”), we may collect and process information and personal data about you. For this reason, in accordance with the applicable provisions of data protection laws, we have created this document (“Privacy Policy”) to describe what personal data we collect, the purposes and methods for processing it and the security measures we take to protect it.


This Privacy Policy constitutes the information that is provided pursuant to applicable laws and exclusively concerns this Website and the processing of data performed by Recordati. Any third-party websites referred to by this Website, including through links, are not covered by the information indicated in this Privacy Policy.


2) WHO PROCESSES YOUR PERSONAL DATA

The data controller is Recordati AG, Rare Diseases Branch with registered office in Uferstrasse 90, 4057 Basel, Switzerland, which is the branch of Recordati AG, with registered office in Lindenstrasse 8, 6340, Baar, Switzerland, (“Recordati”, “we”, “us”) a company of the Recordati Group.


Recordati Industria Chimica e Farmaceutica S.p.A., with registered office in Milano, Via M. Civitali n. 1, enrolled in the Register of Companies of Milan under number 00748210150 shall be the local point of contact and representative in the EU for individuals and data protection authorities.


The Data Protection Officer of the Recordati Group can be contacted for any privacy issue arising or in connection with the processing of Personal Data at the following email address: .


3) WHAT TYPES OF PERSONAL DATA WE PROCESS
  1. Navigation data: The computer systems and software procedures used to operate this Website acquire, during their normal operation, some personal data whose transmission is implicit in the use of internet communication protocols. This information is not collected to be associated with identified data subjects, but by its very nature could, through processing and association with data held by third parties, allow users to be identified. This category of data includes the IP addresses or MAC addresses of the computers used by users who connect to the Website, the URI (Uniform Resource Identifier) addresses of the requested resources, the time of the request, the method used to submit the request to the server, the size of the file obtained in response, the numerical code indicating the status of the response given by the server (successful, error, etc.) and other parameters related to the user’s operating system and IT environment. These data are used to obtain statistical information on the use of the Website and to check its correct functioning. These data could be used to ascertain responsibility in the event of cyber-crimes against the Website, to the extent permitted by applicable legislation.
  2. Data necessary to access to the website, cookies and other similar technologies: Our Website uses cookies and other tracking technologies; for more information, please visit our Cookie Policy.
 
4) FOR WHAT PURPOSES WE PROCESS YOUR PERSONAL DATA

We process your personal data for the following purposes and set out the corresponding legal bases below:


#

Purpose of processing

Legal basis

Types of data

1

To operate, provide you with access to our Website, improve our Site, and troubleshoot any issues.

The processing is based on Recordati’s legitimate interest in presenting its activities to the public, ensuring the functioning of the Website, improving its appearance and user experience.

For this purpose we process data under par. 3, letter a. above.

2

To get to know our visitors through the use of cookies and similar tracking technologies. For more information visit our Cookie Policy.

The processing is based on your consent, where necessary, or on Recordati’s legitimate interest consisting of the interest in ensuring that the Site functions properly, is visible and accessible to users.

For this purpose we process data under par. 3, letter .b above.


Provision of your personal data is not mandatory and will not affect your ability to visit the Website. It may, however, result in the impossibility of sending a request to us.


5) HOW WE PROCESS YOUR PERSONAL DATA

Your personal data will be processed using electronic means.


The security of your personal data is important to us. We adopt – and expect our service providers to adopt – appropriate technical and organizational security measures to prevent the loss or destruction of data, illicit or incorrect use and unauthorized access to data, in compliance with applicable legislation. In addition, the IT systems are configured in such a way that personal and identification data are used only when necessary to achieve the specific processing purposes pursued from time to time.


We implement multiple security technologies and procedures to protect your personal data from the risks described above. However, we would like to point out that electronic transmissions or storage of information are not 100% secure. Therefore, despite the security measures we have put in place to protect your personal data, we cannot guarantee that data loss, misuse or alteration will never occur.

We do not use automated individual decision-making that would have legal effects on you or, similarly, significantly affect you.


6) HOW LONG WE PROCESS YOUR PERSONAL DATA

Personal data is processed for the time necessary to provide the requested information or Services and, in any case, in accordance with any applicable legal or regulatory obligations. Notably:

  • For information on the storage of cookies and other technologies, please visit our Cookie Policy.
7) TO WHOM AND WHERE WE TRANSFER YOUR PERSONAL DATA

Your personal data will be processed by our duly authorised staff, based on their respective needs. Your data will also be processed by our suppliers for technical and organizational services functional to the processing purposes indicated above, such as providers of technical assistance services for the Website and hosting services. All the mentioned service providers act as our data processors on the basis of our instructions and in accordance with the provisions of the contracts they have entered into with us.


We may disclose your personal data to public authorities or bodies and to any other legitimate recipient in accordance with the law. In this case, the recipients will act as independent data controllers according to their respective institutional purposes.


If we are involved in a reorganization, acquisition, or sale of our company or parts of it, we will disclose your personal data to the third parties involved in the process, in accordance with applicable law. Any third party that is the recipient of your personal data as part of this procedure may only use it within the limits established by this Privacy Policy and applicable legislation. To receive the updated list of recipients of your personal data, you can contact us using the contact details indicated above.


If your data is transferred abroad to countries that do not provide the same level of data protection as your country, we will ensure that the transfer is carried out in accordance with applicable law, i.e. by obtaining your consent, when necessary, or by taking any other measures necessary to ensure equivalent protection of the data being transferred, including, but not limited to, through the signing of standard contractual clauses according to the model developed by the European Commission and recognized in Switzerland. You can receive a copy of the relevant safeguards by contact us using the contact details set out in section 2 of this Privacy Policy.


At this stage, we do not transfer your personal data outside of the European Union and Switzerland.


8) WHAT ARE YOUR RIGHTS AND HOW YOU CAN EXERCISE THEM

Recordati informs you that you will always have the right to withdraw your consent at any time, as well as to exercise, at any time, the following rights (subject to certain limitations/restrictions) by contacting the data controller or the DPO at the addresses indicated above:

  1. the “right of access” to your personal data and, in particular, to obtain confirmation of the existence or otherwise of personal data concerning you;
  2. the “right to rectification“, i.e. the right to request the rectification of inaccurate personal data or the completion of incomplete personal data;
  3. the “right to erasure“, i.e. the right to request the erasure, or transformation into anonymous form, of personal data processed;
  4. the “right to restriction of processing“, i.e. the right to obtain from the data controller the restriction of processing in certain cases provided for pursuant to data protection legislation;
  5. the “right to data portability“, i.e. the right to receive (or to transmit directly to another data controller) personal data in a structured, commonly used and machine-readable format;
  6. the “right to object“, i.e. the right to object, in whole or in part:
  • to the processing of personal data carried out by the data controller for its own legitimate interest; and
  • to the processing of personal data carried out by the data controller for marketing or profiling purposes.

The exercise of the above rights is free of charge. However, we may charge a reasonable fee for the administrative costs of complying with a request if it is manifestly unfounded or excessive, or if an individual requests further copies of their data.

All enquiries, requests or concerns regarding this notice or relating to the processing Personal Data including all requests detailed above, should be sent to .


Recordati may ask you to verify your identity before taking further action following your request to exercise the above Rights.

You may also lodge a complaint with the competent supervisory authority (in particular with Swiss Federal Data Protection and Information Commissioner or, for EU countries, with the Data Protection Authority of the Member State of your habitual residence, place of work or place of the alleged violation) if you are of the opinion that your personal data are processed in such a way as to result in violations of applicable data protection legislation. You may also contact the relevant supervisory authority if the exercise of your rights is subject to delay, limitation or exclusion by the data controller.


In order to facilitate the exercise of the right to lodge a complaint, the name and contact details of the supervisory authorities of the European Union are available at the following link: Our Members | European Data Protection Board (europa.eu). You can exercise your right to lodge a complaint to the Swiss Federal Data Protection and Information Commissioner (FDPIC) at the following link Data protection services.


9) CHANGES TO THIS PRIVACY POLICY

We may update and amend all or part of this Privacy Policy at any time. The version published on the Website is the version currently in force. In the event of a change in the text of this Privacy Policy, we will inform you of such changes with a specific banner, link or pop-up on the home page of the Website.

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

This website contains information about products that may not be available in all countries or may be available under different trademarks, for different indications, or in different doses. If you are a US resident please click the button below.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

Você está saindo deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

Você está saindo deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

Você está saindo deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Ahora estás saliendo de este sitio, una página corporativa de Recordati Rare Diseases Iberia. Información para Profesionales Sanitarios.
Ahora estás saliendo de este sitio, una página corporativa de Recordati Rare Diseases Iberia. Información para Profesionales Sanitarios.

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

Réseau des Associations Vouées aux Troubles Sanguins Rares

The NRBDO is a pan Canadian coalition of not-for-profit organizations representing people with rare blood disorders and/or people with a chronic condition who are recipients of blood or blood products or their alternatives.

Lymphoma Canada (Lymphome Canada)

Lorsque l’on est confronté à un lymphome, on se sent vite dépassé. Nous sommes une communauté au sein de laquelle on peut parler de cette maladie qui est le cinquième cancer le plus fréquent au Canada.

Acromégalie Canada

Acromégalie Canada est un organisme à but non lucratif fondé en 2019 pour rassembler les Canadiens dont la vie a été touchée par l’acromégalie. Notre mission est de sensibiliser à l’acromégalie et au gigantisme par l’éducation tout en offrant un réseau de soutien aux patients et à leurs familles à travers le Canada.

Global Genes

Global Genes est une organisation éminente de lutte contre les maladies rares. Sa mission consiste à sensibiliser et éduquer la communauté mondiale ainsi qu’à établir des relations importantes et à fournir des ressources essentielles permettant aux défenseurs de cette cause de s’engager pour lutter contre leur maladie.

Regroupement Québécois des Maladies Orphelines

Par l’entremise de son Centre d’information et de ressources en maladies rares, la RQMO fournit des renseignements et du soutien aux professionnels de la santé, aux patients qui souffrent de maladies rares et orphelines ainsi qu’à leur famille.

Collège canadien de généticiens médicaux

Le CCMG est une organisation nationale canadienne qui aide ses membres, les gouvernements et le public en assurant la certification des personnes, en établissant des normes, en dispensant des formations, et en guidant la politique d’intérêt public.

National Urea Cycle Disorders Foundation (NUCDF, fondation nationale pour les troubles du cycle de l'urée)

La NUCDF (fondation nationale pour les troubles du cycle de l’urée) est dédiée à l’identification, le traitement et la guérison des troubles du cycle de l’urée.

Canadian Organization for Rare Disorders (CORD, organisation canadienne pour les maladies rares)

La CORD (organisation canadienne pour les maladies rares) est le réseau national canadien des organisations représentant toutes les personnes atteintes de maladies rares. La CORD s’engage en vue de promouvoir une politique et un système de santé qui répondent aux besoins des personnes atteintes de maladies rares.

The Garrod Association (l'association Garrod)

The Garrod Association (l’association Garrod) est un organisme canadien permanent à l’échelle nationale dédié à la coordination de la gestion de maladies métaboliques héréditaires.

Association canadienne de porphyrie

L’Association canadienne de porphyrie s’engage à promouvoir la santé en permettant aux personnes atteintes de porphyrie d’avoir accès à un service de conseil et à des informations pertinentes ainsi qu’à des programmes de soutien de groupe.

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Vous quittez Recordatirarediseases.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

Network of Rare Blood Disorder Organizations​

The NRBDO is a pan Canadian coalition of not-for-profit organizations representing people with rare blood disorders and/or people with a chronic condition who are recipients of blood or blood products or their alternatives.

Lymphoma Canada

Dealing with lymphoma can be overwhelming. We are community that helps people talk about and cope with the fifth most common cancer in Canada.

Acromegaly Canada

Acromegaly Canada is a not-for-profit established in 2019 to bring together Canadians whose lives have been touched by acromegaly. Our mission: to raise awareness of acromegaly and gigantism through education while providing a network of support for patients and their families across Canada.

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com

Regroupement Québécois des Maladies Orphelines

Through its Center for Information and Resources on Rare Diseases, RQMO provides information and support to health professionals and to patients with rare and orphan diseases and their families.

Canadian College of Medical Geneticists

CCMG is a national Canadian organization that serves its members, governments and the public by certifying individuals, establishing standards, providing education, and informing public policy.

National Urea Cycle Disorders Foundation

The NUCDF is dedicated to the identification, treatment and cure of urea cycle disorders.

Canadian Organization for Rare Disorders

CORD is Canada’s national network for organizations representing all those with rare disorders. CORD provides a strong common voice to advocate for health policy and a healthcare system that works for those with rare disorders.

The Garrod Association

The Garrod Association is a permanent Canadian body at the national level for the coordination of the management of inherited metabolic disorders.

Global Genes

Global Genes is a leading rare disease advocacy organization. Their mission is to build awareness, educate the global community, and provide critical connections and resources that equip advocates to become activists for their disease.

Canadian Association for Porphyria

The Canadian Association for Porphyria is dedicated to promoting health by providing individuals with porphyria access to related counselling, information, and group support programs.

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
Elisabeth Bergmans
Head of Legal

Elisabeth holds a master degree in corporate and commercial law from the University of Maastricht, and has 17 years experience in the legal profession. She began her career at the Benelux law firm Loyens & Loeff in Amsterdam where she specialized in Private Equity, banking & finance and insolvency & restructuring.


Feeling the need to work closer to the business, Elisabeth then held different positions as Legal Counsel in various industries, such as pension fund investment management, sustainable energy and a private equity fund. In 2015 she joined Teva Pharmaceuticals’ European headquarters in Amsterdam, covering over the years different roles with growing responsibilities; in her last remit she was General Counsel EU Commercial, responsible for the European regional legal support of innovative medicines and commercial HQ activities. In 2021, Elisabeth moved to Milan and continued her activities from there.


In September 2024 she joined Recordati as Head of Legal RRD where she is responsible for the global legal support of the Rare Diseases B.U.

Davide Paganoni
Head of Oncology Franchise

Davide is a biologist with more than 20 years of experience in the Health Care business with a broad commercial experience that ranges from rare disease to OTC.  He joined RRD in 2022, with the acquisition of EUSA, where he used to be Head of Europe and Global Marketing. Prior to EUSA Davide had more experiences as General Manager for biotech and pharma companies as Amryt and Exeltis and before he gained a strong experience in rare disease and ultra-specialistic areas covering senior commercial roles in highly recognized companies like Alexion and Astra Zeneca.

Aziza Johnson
Head of Regulatory Affairs

Aziza Johnson holds a Bachelor of Pharmacy from the London School of Pharmacy and a master’s degree in law from the University of Leicester. She is also a certified Board member, having completed the ZHAW Board of Directors program.

 

Aziza has over 27 years of experience in regulatory affairs, clinical development, and scientific strategy across global pharmaceutical companies and regulatory agencies. She has worked on numerous drug development programs, from clinical trials to market launches, with expertise in orphan drug development, regulatory compliance, and pharmacovigilance. Her career spans leadership roles in both the public and private sectors, including positions at Pfizer and the Medicines and Healthcare products Regulatory Agency (MHRA), where she honed her skills in pharmaceutical regulation and drug approval processes. She also facilitated over 25 successful acquisitions, expanded into new markets, and secured numerous regulatory approvals across the FDA, EMA, MHRA, CFDA, TGA, ANVISA, and Health Canada.

 

In 2023, Aziza joined Recordati Rare Diseases as Head of Regulatory Affairs, where she oversees global regulatory affairs for treatments targeting rare diseases. She leads efforts to secure regulatory approvals across diverse markets, ensuring patients with unmet medical needs receive timely access to innovative therapies.

Francesco Palombi
Head of Finance

Francesco Palombi is an experienced finance executive with over 25 years of global experience across pharmaceuticals, energy, and luxury goods. He holds a Master’s degree in Business Management from the University Cattolica del Sacro Cuore of Milan.

 

He began his career in 1997 at Price Waterhouse and later moved to ENI S.p.A. and Snam Rete Gas, where he managed financial audits, reporting, and external financial statements. In 2005, he joined Roche, advancing to roles including Head of Accounting & Credit Management, Head of Finance & Manufacturing Controlling, and Head of Controlling & Business Analysis.

 

In 2015, he became CFO of Roche Thailand & New Markets, managing finance across multiple countries. He later served as Global Head of Finance for Supply Chain and Product Strategy at Roche, leading financial strategy for global supply chain and product management, before assuming his current role as Global Finance Head at Recordati Rare Diseases in 2022.

Juan-Carlos Gerena
Group Supply Chain Head

Juan Carlos Gerena is a results-driven executive with over 20 years of global experience in manufacturing, supply chain, and business development across diverse industries, including FMCG, pharmaceuticals (branded and generics), and commodities. He has a proven track record of leading large-scale transformations, driving operational excellence, and managing complex end-to-end supply chains in multicultural and international environments.


Currently, as VP of Global Supply Chain at Recordati Group, Juan Carlos oversees the supply chain strategy for both Specialty Pharma and Rare Diseases divisions. Previously, he led global supply operations for renowned organizations like Sobi, Teva Pharmaceuticals, Galderma, Novartis, and Mylan, achieving major milestones such as scaling supply chains to support global expansion, integrating supply networks post-acquisition, and optimizing S&OP processes. His expertise spans strategic sourcing, logistics, CDMO management, pipeline scalability, and digital transformation.


A dynamic leader with a focus on delivering value and operational efficiency, he also played pivotal roles at Shell Oil Products Europe and Unilever, managing complex logistics optimization projects, refinery supply chains, and innovative process development initiatives.


Juan Carlos holds an MBA from the University of Houston and a Bachelor of Science in Industrial Engineering from the University of the Philippines. A skilled communicator, he is fluent in Spanish, English, Italian, and Filipino, with a working knowledge of German. His global mindset, technical expertise, and cultural adaptability make him an influential leader in driving sustainable business growth and supply chain resilience.

Gianni Paniale
Human Resources Director

Gianni holds a degree in Business Administration from Bocconi University in Milan and has built a versatile career spanning management consulting and the pharmaceutical industry.  His professional journey began in 1989 at Proudfoot, a management consulting firm specialising in productivity and quality improvements. Gianni took on progressively senior roles, eventually leading international projects across Italy, France, Germany, the UK, and the Czech Republic.


In 1997, he joined Recordati, initially responsible for the Organisation department, he later assumed leadership of human resources for the commercial organisation in Italy. In 2004, Gianni played a pivotal role in Recordati’s international expansion, leading HR efforts for acquisitions, start-ups and the consolidation of local affiliates.


In 2022, he was appointed Human Resources Director for the Rare Diseases business unit, where he oversaw HR strategies for this specialised and impactful division of the Group. His career reflects a deep commitment to fostering organisational growth and development on both a domestic and global scale.

Georg Thies
Head of Endocrinology Franchise

Georg Thies holds a diploma in Biology and has over 30 years of experience in the pharmaceutical industry.

 

His career in pharma started in 1984 with an apprenticeship at AMERSHAM BUCHLER. He later studied Biology at the GEORG-AUGUST UNIVERSITY in Göttingen and participated in the ERASMUS Program at the KING’S COLLEGE in London.

 

After 2,5 years of civil service, he continued his career at ROCHE in 1995, progressing from Key Account Manager to roles in National and International Marketing for Oncology products.

In 2002 he joined Amgen in Switzerland as International Brand Director for Oncology and Business Unit Head Oncology Switzerland. From 2008 onwards he worked as a Country Director for Sweden.

In 2011, Georg returned to Switzerland, gaining experience in Project- and New Product Planning. He was appointed European Brand Director Cardiovascular in 2012 and European Franchise Director General Medicine in 2014, overseeing Cardiology, Nephrology, Osteoporosis, and Inflammation.

In 2016, he joined SHIRE/TAKEDA, eventually becoming the Global Commercial Executive Director and later VP Global Program Lead in Endocrinology. He concluded his tenure at TAKEDA as Global Commercial Lead Gastrointestinal.

Since August 2022, Georg has been the VP RECORDATI Rare Disease Franchise Head Endocrinology.

Luca Setti
Corporate Portfolio Management Director

Luca Setti is the Corporate Portfolio Management Director at Recordati Rare Diseases, where he is responsible for the evaluation of business development opportunities, and the strategic guidance for life cycle management and pipeline projects.


Luca joined Recordati in July 2020 as Corporate Portfolio Manager, playing a pivotal role in the latest transactions performed by the company in the rare disease space, and in the management of pipeline projects.


Prior to joining Recordati, Luca worked for 10+ years in the business and corporate development departments of Alfasigma and Chiesi Farmaceutici, where he led the completion of multiple asset deals and licensing transactions.


Luca holds a Master’s Degree in Management Engineering from the Politecnico di Milano

Caring for the planet

A clean environment is essential for people’s well-being: the health of the planet and the health of people are closely connected. The air we breathe, the water we drink and the climate we live in all have an impact on our wellbeing. Focusing on people’s health and being sustainable also means prioritising environmental protection while behaving responsibly towards future generations.

 

This is why we ensure we conduct business in a socially responsible manner and in accordance with sustainable practices, national and international laws, and the demands of our stakeholders.

Caring for our communities

Contributing to the well-being of the community and dedicating part of our resources to acts of solidarity is not merely an obligation or professional duty for Recordati but a moral imperative.

 

We believe that caring for the communities in which we’re a part is essential to help them develop and grow, and to foster a sense of pride and belonging among our people.

Our Culture

The Recordati culture is built on the pillars of entrepreneurship, purpose and belonging; all have been part of our company since our beginnings in a small pharmacy in Northern Italy almost 100 years ago.

 

At the heart of our culture are our people, who are focused on always doing the right thing in the right way. We work together – across businesses, borders, time zones and national cultures – to support patients around the world in unlocking the full potential of life.

 

We give people the opportunity to develop themselves and bring their own unique ideas and perspectives to the table. Our culture is one where people can truly be the best versions of themselves, are safe to speak up and empowered to make decisions and experiment, learning as they go.

Diversity & Inclusion

Diversity is at the heart of our business and we do not tolerate any discrimination based on ethnicity, nationality, gender, sexual orientation, disability, age, political or religious belief, or any other personal characteristics.

 

We work hard to create a safe and inclusive work environment, respecting everyone’s right to physical and psychological integrity, as well as freedom of opinion and association. We know that we each of us has a role to play in the success of Recordati and each of us is rewarded for the unique contributions we make, regardless of who we are or where we come from.

Luigi Longinotti
Managing Director and General Manager EMEA

Luigi Longinotti is the Managing Director and General Manager for EMEA at Recordati Rare Diseases, where he oversees the company’s business operations across Europe, the Middle East, and North Africa. In this role, he is responsible for a broad range of functions, including Commercial, Medical Affairs, Marketing, and Market Access as well as key enabling areas such as Human Resources, Finance, Legal, Compliance to support the business’s growth and success.

 

Luigi joined Recordati in July 2014 as Corporate Portfolio Management Director for Orphan Drugs. During his tenure, he played a pivotal role in driving the expansion of the company’s rare disease portfolio, leading efforts in business development, strategic marketing, and the management of pipeline projects.

 

Prior to joining Recordati, Luigi held senior positions in business and corporate development at Chiesi Farmaceutici and Menarini Group, where he successfully led numerous high-impact asset deals and transactions.

Luigi holds a degree in Economics from the University of Florence and a Master’s in Business Innovation from the prestigious Sant’Anna School of Advanced Studies in Pisa.

Bruno Parenti
Head of LAC Region

Bruno Parenti is VP of LAC Region at Recordati Rare Diseases, leading the business in Latin America, Asia Pacific, and Russia. He started opening new markets in 2012, spearheading the expansion of operations around the globe including the direct entry in Japan, China, South Korea, Australia, Brazil, Colombia, Mexico, and Argentina. In the last 2 years, he has successfully integrated the oncology portfolio in the Region, with new launches expanding the access to these life changing therapies to more and more patients.

 

From 2019 to 2022 he has held the additional role of Head of Global Endocrinology, establishing the new HQ in Basel, building from scratch a dedicated organization and coordinating the global launch of Isturisa and the re-launch of Signifor.

 

Prior to these positions, he spent two years at Recordati Ireland overseeing international sales in the Asia-Pacific region. He served at Chiesi Farmaceutici for two years as Area Manager for the Far East. Earlier in his career, he held commercial roles at Kedrion Biopharmaceuticals where he was responsible for international markets with a focus on Latin America and the Middle East.

Mohamed Ladha
President and General Manager, North America

Mohamed Ladha is the President and General Manager at Recordati Rare Diseases where he is  responsible for the US and Canadian business. During his career,  Mohamed has held numerous leadership positions globally in hematology/oncology and specialty care to oversee business in the US, Canada, EU, China, Emerging Markets, and Japan.

 

Mohamed  joins Recordati Rare Diseases from Oncopeptides, where he was the General Manager and Executive Vice President for the US Region Business Unit. Prior to Oncopeptides, he served in a series of leadership positions of increasing responsibility at companies including Vertex Pharmaceuticals, Pfizer, Schering-Plough, Merck & Company, Hospira, ARIAD Pharmaceuticals, Takeda Oncology, and Tocagen. He started his career in basic science research focused in oncology at the Dana-Farber Cancer Institute.

 

Mohamed graduated from Hampshire College with a Bachelor of Arts degree. He also holds professional/graduate degrees from Harvard University’s Kennedy School of Government and Northwestern University’s Kellogg School of Management.

Scott Pescatore
Executive Vice President

Scott Pescatore is Vice President and Head of Global Operations at Recordati Rare Diseases.

He holds a Doctor of Pharmacy degree and completed his post-doctoral fellowship in Pharmacology and Drug Development. Dr Pescatore has spent over 20 years working internationally in the pharmaceutical industry, specializing in oncology, haematology and rare diseases.

He joined Novartis Oncology US in 2001 where he served in various medical, sales and marketing roles of increasing responsibility. In 2008, he moved to Novartis Oncology UK as Business Franchise Head for solid tumours where he also managed the New Products portfolio. In 2010 he moved to Milan to manage the Region Europe Haematology Franchise where he led the joint venture between Novartis Oncology and Incyte to launch a novel treatment for myeloproliferative disorders. In 2014 he was appointed the Oncology General Manager in Ireland and after three years returned to Milan as General Manager of the Region Europe Rare Disease Business Unit, overseeing operations in 37 markets and focusing on the endocrinology portfolio.

Prior to joining Recordati Rare Diseases in 2020, he was Vice President Oncology Business Unit for AstraZeneca Italy where he was responsible for the portfolio of oncology/haematology products including two joint ventures with MSD and Daiichi Sankyo.

You are about to leave this site and visit the recordati global website?

To continue please click the link below.